Abstract:Age-related bone loss and disease strongly affect the quality of life of the elderly population. Cellular circadian rhythms have been reported to regulate bone aging, and micro RNAs (miRNAs) play crucial posttranscriptional regulatory roles in the peripheral clock network. Proliferation capability, osteogenic lineage commitment, senescence-associated secreted phenotype (SASP) and circadian oscillation of clock genes under osteogenic condition were assessed in bone marrow mesenchymal stromal cells (BMSCs) from young adult and aged adult mice. miRNAs targeting the core clock gene brain and muscle arntl-like protein 1 (Bmal1) were screened and verified in young and old BMSCs with RT-qPCR and Western Blot analysis. ChIP-seq and RNA-seq datasets were mined to define the downstream mechanism and gain- and loss-of-function genetic experiments were performed to confirm the hypothesis. To compare the therapeutic effect of these clock-engineered BMSCs, SASP and osteogenic capability of Bmal1-overexpressing and miR-142-3p-inhibited BMSCs were investigated in vitro and transplanted into bone defects and femur cavities of aged mice. Aged BMSCs displayed an abolished circadian rhythm, impaired self-renewal capability and decreased osteoblast differentiation. miR-142-3p was elevated with aging, which downregulated Bmal1 and diminished the osteogenic potential of BMSCs. In addition, Bmal1 inhibited YAP expression to promote BMSCs osteogenesis, which was independent from the activation of Hippo signaling pathway. Overexpression of Bmal1 or inhibition of miR-142-3p rescued the molecular temporal rhythm and osteoblast differentiation ex vivo. Cell-based circadian therapy showed improved bone formation and higher turnover levels in vivo. This study demonstrates that transcriptional and post-transcriptional level clock-modified BMSCs rescued circadian oscillation and age-related bone loss via miR-142-3p/Bmal1/YAP signaling axis. These data provide promising clinical prospects of circadian-mediated stromal cell-based therapy and bone tissue regeneration.

Circadian clock genes as promising therapeutic targets for bone loss

The specificities, influencing factors, and medical implications of bone circadian rhythms

Circadian rhythms affect bone reconstruction by regulating bone energy metabolism

Circadian Regulation of Bone Remodeling

The Circadian Gene Clock Regulates Bone Formation Via Pdia3

Effect of the clock genes on the bone remodeling

Clock-modified Mesenchymal Stromal Cells Therapy Rescues Molecular Circadian Oscillation and Age-Related Bone Loss Via Mir142-3P/bmal1/yap Signaling Axis

Circadian rhythm as a therapeutic target

Unveiling the role of melatonin-related gene CSNK1D in osteoclastogenesis and its implications for osteoporosis treatment

Circadian Clock Disruption Stimulates Bone Loss Via Regulatory T Cell-Mediated Regulation of IL-10 Expression

The circadian clock has roles in mesenchymal stem cell fate decision

Circadian disruption, clock genes, and metabolic health

Genomics of circadian rhythms in health and disease

Deciphering clock genes as emerging targets against aging

Circadian rhythm modulates endochondral bone formation via MTR1/AMPKβ1/BMAL1 signaling axis

Clocks not winding down: unravelling circadian networks

Circadian clock—A promising scientific target in oral science

Major roles of the circadian clock in cancer

Prospects of Circadian Clock in Joint Cartilage Development

Emerging Insight Into the Role of Circadian Clock Gene BMAL1 in Cellular Senescence

The Role of Circadian Clocks in Cancer: Mechanisms and Clinical Implications